Poussot Tapped As Wyeth CEO – Inherits Full Pipeline, Takeover Concerns
Executive Summary
With the appointment of 20-year veteran Bernard Poussot as CEO, Wyeth is following a traditional approach to chief exec succession -avoiding drama by selecting a well-groomed insider with the standard pedigree from the business and marketing sides of the operation
You may also be interested in...
Wyeth Looks To Specialty Markets As Generics Challenge Current Model
Wyeth's R&D pipeline is evolving the firm toward more specialized areas as several of its blockbuster products face patent expirations and generic challenges
Wyeth Looks To Specialty Markets As Generics Challenge Current Model
Wyeth's R&D pipeline is evolving the firm toward more specialized areas as several of its blockbuster products face patent expirations and generic challenges
Lilly Leadership Falls To Lechleiter In ’08 As Taurel Resigns As CEO
The appointment of Lilly President and Chief Operating Officer John Lechleiter to CEO should be a smooth transition in early 2008 when longtime chief exec Sidney Taurel retires